0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Rabies Immune Globulin (HRIG) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-27P8213
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Rabies Immune Globulin HRIG Market Insights Forecast to 2028
BUY CHAPTERS

Global Human Rabies Immune Globulin (HRIG) Market Research Report 2025

Code: QYRE-Auto-27P8213
Report
July 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Rabies Immune Globulin (HRIG) Market

The global market for Human Rabies Immune Globulin (HRIG) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Human rabies immune globulin (HRIG) is a biological product derived from human blood plasma used as passive immunity against rabies virus.
The market for human rabies immune globulin is driven by its critical role in preventing rabies infection after potential exposure to the virus. HRIG provides immediate protection by neutralizing the rabies virus until the body"s immune system produces its antibodies. As rabies remains a significant public health concern in some regions, the demand for HRIG is expected to continue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Rabies Immune Globulin (HRIG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Immune Globulin (HRIG).
The Human Rabies Immune Globulin (HRIG) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Rabies Immune Globulin (HRIG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Immune Globulin (HRIG) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Rabies Immune Globulin (HRIG) Market Report

Report Metric Details
Report Name Human Rabies Immune Globulin (HRIG) Market
Segment by Type
  • 200IU
  • 500IU
Segment by Application
  • Category II Exposure
  • Category III Exposure
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, CNBG, Kamada, CBPO, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Rabies Immune Globulin (HRIG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Rabies Immune Globulin (HRIG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Human Rabies Immune Globulin (HRIG) Market report?

Ans: The main players in the Human Rabies Immune Globulin (HRIG) Market are CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, CNBG, Kamada, CBPO, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS

What are the Application segmentation covered in the Human Rabies Immune Globulin (HRIG) Market report?

Ans: The Applications covered in the Human Rabies Immune Globulin (HRIG) Market report are Category II Exposure, Category III Exposure

What are the Type segmentation covered in the Human Rabies Immune Globulin (HRIG) Market report?

Ans: The Types covered in the Human Rabies Immune Globulin (HRIG) Market report are 200IU, 500IU

1 Human Rabies Immune Globulin (HRIG) Market Overview
1.1 Product Definition
1.2 Human Rabies Immune Globulin (HRIG) by Type
1.2.1 Global Human Rabies Immune Globulin (HRIG) Market Value Comparison by Type (2024 VS 2031)
1.2.2 200IU
1.2.3 500IU
1.3 Human Rabies Immune Globulin (HRIG) by Application
1.3.1 Global Human Rabies Immune Globulin (HRIG) Market Value by Application (2024 VS 2031)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Human Rabies Immune Globulin (HRIG) Market Size Estimates and Forecasts
1.4.1 Global Human Rabies Immune Globulin (HRIG) Revenue 2020-2031
1.4.2 Global Human Rabies Immune Globulin (HRIG) Sales 2020-2031
1.4.3 Global Human Rabies Immune Globulin (HRIG) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Rabies Immune Globulin (HRIG) Market Competition by Manufacturers
2.1 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Rabies Immune Globulin (HRIG) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Rabies Immune Globulin (HRIG), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Rabies Immune Globulin (HRIG), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Rabies Immune Globulin (HRIG), Product Type & Application
2.7 Global Key Manufacturers of Human Rabies Immune Globulin (HRIG), Date of Enter into This Industry
2.8 Global Human Rabies Immune Globulin (HRIG) Market Competitive Situation and Trends
2.8.1 Global Human Rabies Immune Globulin (HRIG) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Rabies Immune Globulin (HRIG) Players Market Share by Revenue
2.8.3 Global Human Rabies Immune Globulin (HRIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Rabies Immune Globulin (HRIG) Market Scenario by Region
3.1 Global Human Rabies Immune Globulin (HRIG) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Rabies Immune Globulin (HRIG) Sales by Region: 2020-2031
3.2.1 Global Human Rabies Immune Globulin (HRIG) Sales by Region: 2020-2025
3.2.2 Global Human Rabies Immune Globulin (HRIG) Sales by Region: 2026-2031
3.3 Global Human Rabies Immune Globulin (HRIG) Revenue by Region: 2020-2031
3.3.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Region: 2020-2025
3.3.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Region: 2026-2031
3.4 North America Human Rabies Immune Globulin (HRIG) Market Facts & Figures by Country
3.4.1 North America Human Rabies Immune Globulin (HRIG) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Rabies Immune Globulin (HRIG) Sales by Country (2020-2031)
3.4.3 North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Rabies Immune Globulin (HRIG) Market Facts & Figures by Country
3.5.1 Europe Human Rabies Immune Globulin (HRIG) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2020-2031)
3.5.3 Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Rabies Immune Globulin (HRIG) Market Facts & Figures by Region
3.6.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Rabies Immune Globulin (HRIG) Market Facts & Figures by Country
3.7.1 Latin America Human Rabies Immune Globulin (HRIG) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Rabies Immune Globulin (HRIG) Sales by Country (2020-2031)
3.7.3 Latin America Human Rabies Immune Globulin (HRIG) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Rabies Immune Globulin (HRIG) Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Rabies Immune Globulin (HRIG) Sales by Type (2020-2031)
4.1.1 Global Human Rabies Immune Globulin (HRIG) Sales by Type (2020-2025)
4.1.2 Global Human Rabies Immune Globulin (HRIG) Sales by Type (2026-2031)
4.1.3 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2020-2031)
4.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2020-2031)
4.2.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2020-2025)
4.2.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2026-2031)
4.2.3 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2020-2031)
4.3 Global Human Rabies Immune Globulin (HRIG) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Rabies Immune Globulin (HRIG) Sales by Application (2020-2031)
5.1.1 Global Human Rabies Immune Globulin (HRIG) Sales by Application (2020-2025)
5.1.2 Global Human Rabies Immune Globulin (HRIG) Sales by Application (2026-2031)
5.1.3 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2020-2031)
5.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2020-2031)
5.2.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2020-2025)
5.2.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2026-2031)
5.2.3 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2020-2031)
5.3 Global Human Rabies Immune Globulin (HRIG) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring Human Rabies Immune Globulin (HRIG) Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Human Rabies Immune Globulin (HRIG) Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Human Rabies Immune Globulin (HRIG) Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sichuan Yuanda Shuyang
6.4.1 Sichuan Yuanda Shuyang Company Information
6.4.2 Sichuan Yuanda Shuyang Description and Business Overview
6.4.3 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product Portfolio
6.4.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.5 CNBG
6.5.1 CNBG Company Information
6.5.2 CNBG Description and Business Overview
6.5.3 CNBG Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CNBG Human Rabies Immune Globulin (HRIG) Product Portfolio
6.5.5 CNBG Recent Developments/Updates
6.6 Kamada
6.6.1 Kamada Company Information
6.6.2 Kamada Description and Business Overview
6.6.3 Kamada Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kamada Human Rabies Immune Globulin (HRIG) Product Portfolio
6.6.5 Kamada Recent Developments/Updates
6.7 CBPO
6.7.1 CBPO Company Information
6.7.2 CBPO Description and Business Overview
6.7.3 CBPO Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CBPO Human Rabies Immune Globulin (HRIG) Product Portfolio
6.7.5 CBPO Recent Developments/Updates
6.8 Shuanglin Bio
6.8.1 Shuanglin Bio Company Information
6.8.2 Shuanglin Bio Description and Business Overview
6.8.3 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product Portfolio
6.8.5 Shuanglin Bio Recent Developments/Updates
6.9 Weiguang Bio
6.9.1 Weiguang Bio Company Information
6.9.2 Weiguang Bio Description and Business Overview
6.9.3 Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Weiguang Bio Human Rabies Immune Globulin (HRIG) Product Portfolio
6.9.5 Weiguang Bio Recent Developments/Updates
6.10 Shanghai RAAS
6.10.1 Shanghai RAAS Company Information
6.10.2 Shanghai RAAS Description and Business Overview
6.10.3 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product Portfolio
6.10.5 Shanghai RAAS Recent Developments/Updates
6.11 Bharat Serum
6.11.1 Bharat Serum Company Information
6.11.2 Bharat Serum Description and Business Overview
6.11.3 Bharat Serum Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bharat Serum Human Rabies Immune Globulin (HRIG) Product Portfolio
6.11.5 Bharat Serum Recent Developments/Updates
6.12 VINS
6.12.1 VINS Company Information
6.12.2 VINS Description and Business Overview
6.12.3 VINS Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 VINS Human Rabies Immune Globulin (HRIG) Product Portfolio
6.12.5 VINS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Rabies Immune Globulin (HRIG) Industry Chain Analysis
7.2 Human Rabies Immune Globulin (HRIG) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Rabies Immune Globulin (HRIG) Production Mode & Process Analysis
7.4 Human Rabies Immune Globulin (HRIG) Sales and Marketing
7.4.1 Human Rabies Immune Globulin (HRIG) Sales Channels
7.4.2 Human Rabies Immune Globulin (HRIG) Distributors
7.5 Human Rabies Immune Globulin (HRIG) Customer Analysis
8 Human Rabies Immune Globulin (HRIG) Market Dynamics
8.1 Human Rabies Immune Globulin (HRIG) Industry Trends
8.2 Human Rabies Immune Globulin (HRIG) Market Drivers
8.3 Human Rabies Immune Globulin (HRIG) Market Challenges
8.4 Human Rabies Immune Globulin (HRIG) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human Rabies Immune Globulin (HRIG) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Rabies Immune Globulin (HRIG) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Rabies Immune Globulin (HRIG) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Rabies Immune Globulin (HRIG) Sales (Kiloton) of Key Manufacturers (2020-2025)
 Table 5. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Rabies Immune Globulin (HRIG) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Rabies Immune Globulin (HRIG) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Rabies Immune Globulin (HRIG) Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Rabies Immune Globulin (HRIG), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Rabies Immune Globulin (HRIG), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Rabies Immune Globulin (HRIG), Product Type & Application
 Table 12. Global Key Manufacturers of Human Rabies Immune Globulin (HRIG), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Rabies Immune Globulin (HRIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immune Globulin (HRIG) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Rabies Immune Globulin (HRIG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Rabies Immune Globulin (HRIG) Sales by Region (2020-2025) & (Kiloton)
 Table 18. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2020-2025)
 Table 19. Global Human Rabies Immune Globulin (HRIG) Sales by Region (2026-2031) & (Kiloton)
 Table 20. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2026-2031)
 Table 21. Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Rabies Immune Globulin (HRIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Rabies Immune Globulin (HRIG) Sales by Country (2020-2025) & (Kiloton)
 Table 27. North America Human Rabies Immune Globulin (HRIG) Sales by Country (2026-2031) & (Kiloton)
 Table 28. North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Rabies Immune Globulin (HRIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2020-2025) & (Kiloton)
 Table 32. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2026-2031) & (Kiloton)
 Table 33. Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2020-2025) & (Kiloton)
 Table 37. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2026-2031) & (Kiloton)
 Table 38. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Rabies Immune Globulin (HRIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Rabies Immune Globulin (HRIG) Sales by Country (2020-2025) & (Kiloton)
 Table 42. Latin America Human Rabies Immune Globulin (HRIG) Sales by Country (2026-2031) & (Kiloton)
 Table 43. Latin America Human Rabies Immune Globulin (HRIG) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Rabies Immune Globulin (HRIG) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2020-2025) & (Kiloton)
 Table 47. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2026-2031) & (Kiloton)
 Table 48. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Rabies Immune Globulin (HRIG) Sales (Kiloton) by Type (2020-2025)
 Table 51. Global Human Rabies Immune Globulin (HRIG) Sales (Kiloton) by Type (2026-2031)
 Table 52. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2020-2025)
 Table 53. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2026-2031)
 Table 54. Global Human Rabies Immune Globulin (HRIG) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Rabies Immune Globulin (HRIG) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Rabies Immune Globulin (HRIG) Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Human Rabies Immune Globulin (HRIG) Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Human Rabies Immune Globulin (HRIG) Sales (Kiloton) by Application (2020-2025)
 Table 61. Global Human Rabies Immune Globulin (HRIG) Sales (Kiloton) by Application (2026-2031)
 Table 62. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2020-2025)
 Table 63. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2026-2031)
 Table 64. Global Human Rabies Immune Globulin (HRIG) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Rabies Immune Globulin (HRIG) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Rabies Immune Globulin (HRIG) Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Human Rabies Immune Globulin (HRIG) Price (US$/Ton) by Application (2026-2031)
 Table 70. CSL Behring Company Information
 Table 71. CSL Behring Description and Business Overview
 Table 72. CSL Behring Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. CSL Behring Human Rabies Immune Globulin (HRIG) Product
 Table 74. CSL Behring Recent Developments/Updates
 Table 75. Grifols Company Information
 Table 76. Grifols Description and Business Overview
 Table 77. Grifols Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Grifols Human Rabies Immune Globulin (HRIG) Product
 Table 79. Grifols Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Sanofi Human Rabies Immune Globulin (HRIG) Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Sichuan Yuanda Shuyang Company Information
 Table 86. Sichuan Yuanda Shuyang Description and Business Overview
 Table 87. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product
 Table 89. Sichuan Yuanda Shuyang Recent Developments/Updates
 Table 90. CNBG Company Information
 Table 91. CNBG Description and Business Overview
 Table 92. CNBG Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. CNBG Human Rabies Immune Globulin (HRIG) Product
 Table 94. CNBG Recent Developments/Updates
 Table 95. Kamada Company Information
 Table 96. Kamada Description and Business Overview
 Table 97. Kamada Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Kamada Human Rabies Immune Globulin (HRIG) Product
 Table 99. Kamada Recent Developments/Updates
 Table 100. CBPO Company Information
 Table 101. CBPO Description and Business Overview
 Table 102. CBPO Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. CBPO Human Rabies Immune Globulin (HRIG) Product
 Table 104. CBPO Recent Developments/Updates
 Table 105. Shuanglin Bio Company Information
 Table 106. Shuanglin Bio Description and Business Overview
 Table 107. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product
 Table 109. Shuanglin Bio Recent Developments/Updates
 Table 110. Weiguang Bio Company Information
 Table 111. Weiguang Bio Description and Business Overview
 Table 112. Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Weiguang Bio Human Rabies Immune Globulin (HRIG) Product
 Table 114. Weiguang Bio Recent Developments/Updates
 Table 115. Shanghai RAAS Company Information
 Table 116. Shanghai RAAS Description and Business Overview
 Table 117. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product
 Table 119. Shanghai RAAS Recent Developments/Updates
 Table 120. Bharat Serum Company Information
 Table 121. Bharat Serum Description and Business Overview
 Table 122. Bharat Serum Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Bharat Serum Human Rabies Immune Globulin (HRIG) Product
 Table 124. Bharat Serum Recent Developments/Updates
 Table 125. VINS Company Information
 Table 126. VINS Description and Business Overview
 Table 127. VINS Human Rabies Immune Globulin (HRIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. VINS Human Rabies Immune Globulin (HRIG) Product
 Table 129. VINS Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Human Rabies Immune Globulin (HRIG) Distributors List
 Table 133. Human Rabies Immune Globulin (HRIG) Customers List
 Table 134. Human Rabies Immune Globulin (HRIG) Market Trends
 Table 135. Human Rabies Immune Globulin (HRIG) Market Drivers
 Table 136. Human Rabies Immune Globulin (HRIG) Market Challenges
 Table 137. Human Rabies Immune Globulin (HRIG) Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Rabies Immune Globulin (HRIG)
 Figure 2. Global Human Rabies Immune Globulin (HRIG) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Rabies Immune Globulin (HRIG) Market Share by Type: 2024 & 2031
 Figure 4. 200IU Product Picture
 Figure 5. 500IU Product Picture
 Figure 6. Global Human Rabies Immune Globulin (HRIG) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Rabies Immune Globulin (HRIG) Market Share by Application: 2024 & 2031
 Figure 8. Category II Exposure
 Figure 9. Category III Exposure
 Figure 10. Global Human Rabies Immune Globulin (HRIG) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Human Rabies Immune Globulin (HRIG) Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Human Rabies Immune Globulin (HRIG) Sales (2020-2031) & (Kiloton)
 Figure 13. Global Human Rabies Immune Globulin (HRIG) Average Price (US$/Ton) & (2020-2031)
 Figure 14. Human Rabies Immune Globulin (HRIG) Report Years Considered
 Figure 15. Human Rabies Immune Globulin (HRIG) Sales Share by Manufacturers in 2024
 Figure 16. Global Human Rabies Immune Globulin (HRIG) Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Human Rabies Immune Globulin (HRIG) Players: Market Share by Revenue in Human Rabies Immune Globulin (HRIG) in 2024
 Figure 18. Human Rabies Immune Globulin (HRIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Human Rabies Immune Globulin (HRIG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2020-2031)
 Figure 21. North America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2020-2031)
 Figure 22. United States Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2020-2031)
 Figure 25. Europe Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2020-2031)
 Figure 33. China Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Human Rabies Immune Globulin (HRIG) by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Human Rabies Immune Globulin (HRIG) by Type (2020-2031)
 Figure 54. Global Human Rabies Immune Globulin (HRIG) Price (US$/Ton) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Human Rabies Immune Globulin (HRIG) by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Human Rabies Immune Globulin (HRIG) by Application (2020-2031)
 Figure 57. Global Human Rabies Immune Globulin (HRIG) Price (US$/Ton) by Application (2020-2031)
 Figure 58. Human Rabies Immune Globulin (HRIG) Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart